Annovis Bio Inc reports results for the quarter ended in December - Earnings Summary

Annovis Bio

01/04/2024 14:31

* Annovis Bio Inc  ANVS.N  reported a quarterly adjusted
loss of
$2.24​​ per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of -38
cents.  The mean expectation of five analysts for the quarter
was for a loss of $1.30 per share. Wall Street expected
results to range from $-1.63 to $-1.06 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Annovis Bio Inc's reported EPS for the quarter was a loss
of
$2.24​.
    * The company reported a quarterly loss of $22.21 million.
    * Annovis Bio Inc shares had held steady so far this
quarter and
lost 36.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 3.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Annovis Bio Inc
is $30.00 
This summary was machine generated from LSEG data April 1 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -1.30          -2.24          Missed
 Sep. 30 2023      -1.09          -1.63          Missed
 Jun. 30 2023      -1.14          -1.07          Beat
 Mar. 31 2023      -0.33          -1.19          Missed